Edition:
United States

Profile: Atrion Corp (ATRI.O)

ATRI.O on Nasdaq

655.45USD
23 Oct 2017
Change (% chg)

$-19.55 (-2.90%)
Prev Close
$675.00
Open
$661.40
Day's High
$671.60
Day's Low
$654.50
Volume
5,038
Avg. Vol
6,612
52-wk High
$694.00
52-wk Low
$426.20

Atrion Corporation (Atrion) is engaged in developing and manufacturing products, primarily for medical applications. The Company's medical products range from fluid delivery devices to ophthalmic and cardiovascular products. Its fluid delivery products include valves that promote infection control and needle safety. It has developed a range of valves designed to fill, hold and release controlled amounts of fluids or gasses on demand for use in various intubation, intravenous, catheter and other applications in areas, such as anesthesia and oncology. Its cardiovascular product, MPS2 Myocardial Protection System (MPS2), is the system used in open-heart surgery that delivers fluids and medications, mixes critical drugs and controls temperature, pressure and other variables. The Company manufactures specialized medical devices that disinfect contact lenses. Its other medical and non-medical product lines consist of instrumentation and associated disposables.

Company Address

Atrion Corp

1 Allentown Pkwy
ALLEN   TX   75002-4206
P: +1972.3909800
F: +1972.3967581

Company Web Links